Journey Medical Corporation

NasdaqCM:DERM Stock Report

Market Cap: US$109.5m

Journey Medical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Claude Maraoui

Chief executive officer

US$934.5k

Total compensation

CEO salary percentage58.9%
CEO tenure10.4yrs
CEO ownership2.6%
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

Journey Medical (NASDAQ:DERM) Has Debt But No Earnings; Should You Worry?

Feb 06
Journey Medical (NASDAQ:DERM) Has Debt But No Earnings; Should You Worry?

Market Cool On Journey Medical Corporation's (NASDAQ:DERM) Revenues Pushing Shares 26% Lower

Jan 11
Market Cool On Journey Medical Corporation's (NASDAQ:DERM) Revenues Pushing Shares 26% Lower

Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Oct 03
Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Mar 11
Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Jan 18
Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Nov 10
Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

May 12
US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

CEO Compensation Analysis

How has Claude Maraoui's remuneration changed compared to Journey Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$18m

Jun 30 2024n/an/a

US$843k

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$934kUS$550k

-US$4m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$39m

Mar 31 2023n/an/a

-US$38m

Dec 31 2022US$2mUS$474k

-US$30m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$41m

Mar 31 2022n/an/a

-US$46m

Dec 31 2021US$2mUS$464k

-US$44m

Sep 30 2021n/an/a

-US$20m

Jun 30 2021n/an/a

-US$9m

Mar 31 2021n/an/a

US$4m

Dec 31 2020US$2mUS$450k

US$5m

Compensation vs Market: Claude's total compensation ($USD934.45K) is above average for companies of similar size in the US market ($USD638.32K).

Compensation vs Earnings: Claude's compensation has been consistent with company performance over the past year.

CEO

Claude Maraoui (57 yo)

10.4yrs

Tenure

US$934,450

Compensation

Mr. Claude Maraoui is Founder and Director of Journey Medical Corporation since 2016 and its President and Chief Executive Officer since September 2014. Mr. Maraoui has experience in launching and commerci...

Board Members

NamePositionTenureCompensationOwnership
Lindsay Rosenwald
Executive Chairman10.3yrsUS$50.00k1.54%
$ 1.7m
Claude Maraoui
Founder9.1yrsUS$934.45k2.59%
$ 2.8m
Michael Pearce
Directorless than a yearno datano data
Neil Herskowitz
Independent Director3.3yrsUS$110.00k0.21%
$ 231.8k
Justin Smith
Independent Director3.3yrsUS$100.00k0.51%
$ 562.0k
Miranda Toledano
Independent Director3.3yrsUS$100.00k0.21%
$ 231.8k

3.3yrs

Average Tenure

59.5yo

Average Age

Experienced Board: DERM's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 04:02
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Journey Medical Corporation is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Kalpit PatelB. Riley Securities, Inc.
Brandon FolkesCantor Fitzgerald & Co.